Kintara Therapeutics Announces Data Presentation at the 2023 American Association for Cancer Research Annual Meeting

Provided By PR Newswire

Last update: Apr 14, 2023

SAN DIEGO, April 14, 2023 /PRNewswire/ -- Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announced its participation in the upcoming 2023 American Association for Cancer Research (AACR) Annual Meeting, taking place in Orlando, Florida from April 14 through April 19, 2023, where VAL-083 data will be presented.